Bottom line
AHSAX vs GGHCX: the short answer
AHSAX (Alger Health Sciences Fund) and GGHCX (INVESCO Health Care Fund) are both mutual funds.
GGHCX is cheaper at 1.07% vs 1.17% — a difference of $10 a year per $10,000 invested.
Over five years, GGHCX returned +2.6% a year vs −3.0% for AHSAX.
Updated Nov 19, 2026
AHSAX vs GGHCX side by side
| AHSAX | GGHCX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Alger | Invesco |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.17% | 1.07% |
| Annual cost per $10k | $117 | $107 |
| 10-yr cost on $10k (prospectus) | $1,871 | $1,784 |
| Max front load | 5.25% | 5.5% |
| 12b-1 fee | 0.25% | 0.25% |
| 1-yr return | +4.4% | +9.2% |
| 5-yr return (annualized) | −3.0% | +2.6% |
| 10-yr return (annualized) | +6.8% | +5.8% |
| Best quarter | +24.5% | +19.6% |
| Worst quarter | −18.7% | −16.5% |
| Net assets (fund) | $75.4M | $1.2B |
| Number of holdings | 55 | 82 |
| Portfolio turnover | 289% | 59% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | AHSAX | GGHCX | Difference |
|---|---|---|---|
| 2025 | +10.2% | +15.5% | −5.3% |
| 2024 | +1.2% | +4.0% | −2.8% |
| 2023 | −4.3% | +3.1% | −7.3% |
| 2022 | −17.0% | −13.5% | −3.5% |
| 2021 | +2.5% | +12.2% | −9.7% |
| 2020 | +31.0% | +14.5% | +16.5% |
| 2019 | +22.0% | +32.0% | −10.0% |
| 2018 | +5.8% | +0.5% | +5.3% |
| 2017 | +37.2% | +15.5% | +21.7% |
| 2016 | −3.3% | −11.7% | +8.4% |
Source: Fund prospectus bar charts
Holdings overlap
9 of AHSAX's top 25 holdings also appear in GGHCX's top 25.
| Holding | AHSAX | GGHCX |
|---|---|---|
| Merck & Company Inc | 4.18% | 4.59% |
| Welltower Inc | 4.12% | 2.34% |
| Johnson & Johnson | 4.06% | 6.76% |
| Thermo Fisher Scientific Inc | 4.00% | 1.55% |
| Cvs Health Corp | 3.67% | 2.52% |
| Unitedhealth Group Inc | 3.61% | 6.17% |
| Eli Lilly & Company | 3.29% | 10.59% |
| Guardant Health Inc | 1.81% | 2.04% |
| Vertex Pharmaceuticals Inc | 1.80% | 2.01% |
Source: SEC Form N-PORT
AHSAX top 10
- Dreyfus Treasury Obligations Cash Management — 6.51%
- Impulse Dynamics Ireland — 4.27%
- Merck & Company Inc — 4.18%
- Welltower Inc — 4.12%
- Johnson & Johnson — 4.06%
- Thermo Fisher Scientific Inc — 4.00%
- Bruker Corp — 3.98%
- Illumina Inc — 3.95%
- Cvs Health Corp — 3.67%
- Unitedhealth Group Inc — 3.61%
GGHCX top 10
- Eli Lilly and Co. — 10.59%
- Johnson & Johnson — 6.76%
- UnitedHealth Group Inc. — 6.17%
- Invesco Private Prime Fund — 4.67%
- Merck & Co., Inc. — 4.59%
- AbbVie Inc. — 4.03%
- Gilead Sciences, Inc. — 3.63%
- argenx SE — 3.24%
- CVS Health Corp. — 2.52%
- Welltower Inc. — 2.34%
FAQ
What is the difference between AHSAX and GGHCX?
Which is cheaper, AHSAX or GGHCX?
Should I own both AHSAX and GGHCX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.